{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:18:09Z","timestamp":1791987489874,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2023\/51\/B\/NZ1\/03027"],"award-info":[{"award-number":["2023\/51\/B\/NZ1\/03027"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1\\u2013156\\u201304\/503\\u201311\\u2013001"],"award-info":[{"award-number":["503\/1\\u2013156\\u201304\/503\\u201311\\u2013001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biocel.2026.106989","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:27:47Z","timestamp":1781627267000},"page":"106989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview"],"prefix":"10.1016","volume":"199","author":[{"given":"Julia","family":"Jarzabek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jaczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Salaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2026.106989_bib1","doi-asserted-by":"crossref","first-page":"G678","DOI":"10.1152\/ajpgi.00158.2014","article-title":"Fibroblast growth factor 10 alters the balance between goblet and Paneth cells in the adult mouse small intestine","volume":"308","author":"Al Alam","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biocel.2026.106989_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186142","article-title":"Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles","volume":"12","author":"Andersson","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.biocel.2026.106989_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00054725-199902000-00007","article-title":"Growth factors in inflammatory bowel disease","volume":"5","author":"Beck","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biocel.2026.106989_bib4","article-title":"FGF12: biology and function","volume":"139","author":"Biadun","year":"2024","journal-title":"Differ. Res. Biol. Divers."},{"key":"10.1016\/j.biocel.2026.106989_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jbiotec.2025.03.016","article-title":"Production and purification of recombinant long protein isoforms of FGF11 subfamily","volume":"403","author":"Biadun","year":"2025","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biocel.2026.106989_bib6","article-title":"FGF homologous factors are secreted from cells to induce FGFR-mediated anti-apoptotic response","volume":"37","author":"Biadun","year":"2023","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.biocel.2026.106989_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncb1082","article-title":"The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling","volume":"6","author":"B\u00f6ttcher","year":"2004","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biocel.2026.106989_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ecco-jcc\/jjab157","article-title":"The effect of phenotype and genotype on the plasma proteome in patients with inflammatory bowel disease","volume":"16","author":"Bourgonje","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biocel.2026.106989_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2023.04.007","article-title":"Effects of FGF19 analogue aldafermin in patients with bile acid diarrhea: a randomized, placebo-control trial","volume":"165","author":"BouSaba","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2026.106989_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1023\/A:1018882322566","article-title":"Serum basic fibroblast growth factor in pediatric Crohn\u2019s disease. Implications for wound healing","volume":"42","author":"Bousvaros","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biocel.2026.106989_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.277137.115","article-title":"Genetic insights into the mechanisms of Fgf signaling","volume":"30","author":"Brewer","year":"2016","journal-title":"Genes. Dev."},{"key":"10.1016\/j.biocel.2026.106989_bib12","doi-asserted-by":"crossref","first-page":"G690","DOI":"10.1152\/ajpgi.00314.2001","article-title":"rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease","volume":"282","author":"Byrne","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biocel.2026.106989_bib13","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14003","article-title":"Phenotypic spectrum of FGF10-related disorders: a systematic review","volume":"10","author":"Bzdega","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.biocel.2026.106989_bib14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.0000118600.91698.BB","article-title":"Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability","volume":"94","author":"Cao","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.biocel.2026.106989_bib15","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2026.106989_bib16","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis","volume":"101","author":"Chang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biocel.2026.106989_bib17","first-page":"344","article-title":"Fibroblast growth factors in the gastrointestinal tract: twists and turns","volume":"246","author":"Danopoulos","year":"2017","journal-title":"Dev. Dyn. Publ. Am. Assoc. Anat."},{"key":"10.1016\/j.biocel.2026.106989_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biocel.2026.106989_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00054725-200409000-00011","article-title":"Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn\u2019s disease","volume":"10","author":"Di Sabatino","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biocel.2026.106989_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00042737-200107000-00002","article-title":"Peptide growth factors in the intestine","volume":"13","author":"Dignass","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biocel.2026.106989_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/0016-5085(94)90017-5","article-title":"Fibroblast growth factors modulate intestinal epithelial cell growth and migration","volume":"106","author":"Dignass","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2026.106989_bib22","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cells10113242","article-title":"The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration","volume":"10","author":"Farooq","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biocel.2026.106989_bib23","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1111\/bph.70049","article-title":"FGF1\u0394HBS ameliorates DSS-induced ulcerative colitis by reducing neutrophil recruitment through the MAPK pathway","volume":"182","author":"Feng","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biocel.2026.106989_bib24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jcmm.12091","article-title":"Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models","volume":"17","author":"Finch","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"24","key":"10.1016\/j.biocel.2026.106989_bib25","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1158\/1078-0432.CCR-04-1118","article-title":"Phase I\/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation","volume":"10","author":"Freytes","year":"2004","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biocel.2026.106989_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.biocel.2026.106989_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biocel.2026.106989_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s42255-019-0074-3","article-title":"Metabolic messengers: fibroblast growth factor 15\/19","volume":"1","author":"Gadaleta","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biocel.2026.106989_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","article-title":"The role of goblet cells and mucus in intestinal homeostasis","volume":"19","author":"Gustafsson","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biocel.2026.106989_bib30","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1007\/s11033-022-07732-3","article-title":"Genotyping helicobacter pylori and fgf7 gene expression in gastric cancer","volume":"49","author":"Hedayati","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biocel.2026.106989_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biocel.2026.106989_bib32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/gast.2002.36041","article-title":"A novel human fibroblast growth factor treats experimental intestinal inflammation","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2026.106989_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113044","article-title":"FGF20 modulates gut microbiota to mitigate dextran sodium sulfate-induced ulcerative colitis in mouse models","volume":"142","author":"Jin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biocel.2026.106989_bib34","first-page":"822","article-title":"VEGF, basic-FGF, and TGF-beta in Crohn\u2019s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation","volume":"96","author":"Kanazawa","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biocel.2026.106989_bib35","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2026.106989_bib36","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.29.1.163","article-title":"FGF signaling network in the gastrointestinal tract (Review)","author":"Katoh","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biocel.2026.106989_bib37","doi-asserted-by":"crossref","first-page":"13008","DOI":"10.3390\/ijms252313008","article-title":"Fibroblast heterogeneity in inflammatory bowel disease","volume":"25","author":"Ke","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biocel.2026.106989_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biocel.2026.106989_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ibd.21316","article-title":"Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing","volume":"17","author":"Krishnan","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biocel.2026.106989_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365521.2014.968863","article-title":"Mechanisms of initiation and progression of intestinal fibrosis in IBD","volume":"50","author":"Latella","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.biocel.2026.106989_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1097-2765(02)00689-5","article-title":"The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors","volume":"10","author":"Lax","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biocel.2026.106989_bib42","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1038\/s41467-025-58644-2","article-title":"Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease","volume":"16","author":"Lin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biocel.2026.106989_bib43","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/ibd.21554","article-title":"Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: a review","volume":"17","author":"Linares","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biocel.2026.106989_bib44","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/nu15092086","article-title":"FGF21 depletion attenuates colitis through intestinal epithelial IL-22-STAT3 activation in mice","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biocel.2026.106989_bib45","first-page":"102","article-title":"Pegbelfermin in patients with nonalcoholic steatohepatitis and stage 3 fibrosis (FALCON 1): a randomized phase 2b study","volume":"22","author":"Loomba","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.biocel.2026.106989_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1394030","article-title":"A correlation of serum fibroblast growth factor 21 level with inflammatory markers and indicators of nutritional status in patients with inflammatory bowel disease","volume":"15","author":"\u0141ukawska","year":"2024","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biocel.2026.106989_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fcell.2019.00326","article-title":"Role of FGF10\/FGFR2b signaling in mouse digestive tract development, repair and regeneration following injury","volume":"7","author":"Lv","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biocel.2026.106989_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MEG.0000000000001925","article-title":"Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease","volume":"33","author":"Lyutakov","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biocel.2026.106989_bib49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5152\/tjg.2021.20247","article-title":"Serum levels of fibroblast growth factor 19 correlate with the severity of diarrhea and independently from intestinal inflammation in patients with inflammatory bowel disease or microscopic colitis","volume":"32","author":"Lyutakov","year":"2021","journal-title":"Turk. J. Gastroenterol. J. Turk. Soc. Gastroenterol."},{"key":"10.1016\/j.biocel.2026.106989_bib50","first-page":"504","article-title":"Hafezi-Moghadam A. Lymphangiogenesis and angiogenesis: concurrence and\/or dependence? Studies in inbred mouse strains","volume":"24","author":"Nakao","year":"2010","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.biocel.2026.106989_bib51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2012.04.042","article-title":"Structural stability of human fibroblast growth factor-1 is essential for protective effects against radiation-induced intestinal damage","volume":"85","author":"Nakayama","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biocel.2026.106989_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ecco-jcc\/jju022","article-title":"Diarrhea in Crohn\u2019s disease: investigating the role of the ileal hormone fibroblast growth factor 19","volume":"9","author":"Nolan","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biocel.2026.106989_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.biocel.2026.106989_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2389312","article-title":"An inverse correlation of serum fibroblast growth factor 19 with abdominal pain and inflammatory markers in patients with ulcerative colitis","volume":"2020","author":"Panek-Jeziorna","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.biocel.2026.106989_bib55","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1111\/febs.70218","article-title":"N-terminal helix formation and dimer\u2013monomer transition of FGF10 in specific recognition of FGFR2b","volume":"292","author":"Park","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.biocel.2026.106989_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-811X-4-7","article-title":"Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers","volume":"4","author":"Planque","year":"2006","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biocel.2026.106989_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae197","article-title":"Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease","author":"Preto","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biocel.2026.106989_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79341-y","article-title":"Comprehensive analysis identifies endocrine fibroblast growth factors as promising prognostic markers for colorectal carcinoma","volume":"14","author":"Rejali","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2026.106989_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/HEP.0000000000000607","article-title":"A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis","volume":"79","author":"Rinella","year":"2024","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biocel.2026.106989_bib60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1046\/j.1365-2036.2003.01589.x","article-title":"Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"17","author":"Sandborn","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.biocel.2026.106989_bib61","first-page":"1493","article-title":"Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization","volume":"73","author":"Shen","year":"2024","journal-title":"Inflamm. Res. J. Eur. Histamine Res. Soc. Al"},{"key":"10.1016\/j.biocel.2026.106989_bib62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1091\/mbc.e05-04-0368","article-title":"Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis","volume":"17","author":"Shin","year":"2006","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.biocel.2026.106989_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.1238842","article-title":"Villification: how the gut gets its villi","volume":"342","author":"Shyer","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biocel.2026.106989_bib64","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2015.06.024","article-title":"Growth factor FGF2 cooperates with interleukin-17 to repair intestinal epithelial damage","volume":"43","author":"Song","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biocel.2026.106989_bib65","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15247","article-title":"Fibroblast growth factor-23 and parathyroid hormone suppress small intestinal magnesium absorption","volume":"10","author":"Suksridechacin","year":"2022","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biocel.2026.106989_bib66","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/003655200750023985","article-title":"R. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis","volume":"35","author":"Th\u00f6rn","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biocel.2026.106989_bib67","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000321809","article-title":"FGF19 protects colonic epithelial cells against hydrogen peroxide","volume":"83","author":"Uchiyama","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.biocel.2026.106989_bib68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrgastro.2014.32","article-title":"Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy","volume":"11","author":"Walters","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biocel.2026.106989_bib69","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1159\/000543259","article-title":"Identifying novel inflammatory protein biomarkers and drug targets of inflammatory bowel disease by integrating mendelian randomization, bioinformatics, and druggability analysis","volume":"186","author":"Wang","year":"2025","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.biocel.2026.106989_bib70","article-title":"Hydrogel derived from decellularized pig small intestine submucosa boosted the therapeutic effect of FGF-20 on TNBS-induced colitis in rats via restoring gut mucosal integrity","volume":"32","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biocel.2026.106989_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154806","article-title":"Alginate oligosaccharide alleviates aging-related intestinal mucosal barrier dysfunction by blocking FGF1-mediated TLR4\/NF-\u03baB p65 pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biocel.2026.106989_bib72","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41598-020-58644-w","article-title":"Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn\u2019s disease","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2026.106989_bib73","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biocel.2026.106989_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000320773","article-title":"Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis","volume":"84","author":"Yamagata","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.biocel.2026.106989_bib75","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/218142","article-title":"Fibroblast growth factors: biology, function, and application for tissue regeneration","volume":"1","author":"Yun","year":"2010","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.biocel.2026.106989_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s43042-024-00533-2","article-title":"Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-\u03b1 as a marker of disease severity","volume":"25","author":"Zaki","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.biocel.2026.106989_bib77","article-title":"Crohn\u2019s disease: research progress in decoding pathogenic multi-network and precision management of artificial intelligence radiomics","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biocel.2026.106989_bib78","article-title":"Fibroblast growth factor 20 attenuates colitis by restoring impaired intestinal epithelial barrier integrity and modulating macrophage polarization via S100A9 in an NF-\u03baB-dependent manner","volume":"19","author":"Zhen","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biocel.2026.106989_bib79","article-title":"Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2026.106989_bib80","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-025-02571-7","article-title":"Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study","author":"Zhou","year":"2025","journal-title":"Acta Diabetol."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:57:25Z","timestamp":1786431445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272526000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"alternative-id":["S1357272526000932"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2026.106989","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2026.106989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106989"}}